Pictet Asset Management Holding SA Buys 24,832 Shares of Astera Labs, Inc. $ALAB

Pictet Asset Management Holding SA boosted its stake in Astera Labs, Inc. (NASDAQ:ALAB) by 29.7% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 108,340 shares of the company’s stock after purchasing an additional 24,832 shares during the quarter. Pictet Asset Management Holding SA owned about 0.06% of Astera Labs worth $38,566,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in the stock. Greenleaf Trust boosted its holdings in Astera Labs by 1.8% during the second quarter. Greenleaf Trust now owns 2,000 shares of the company’s stock worth $966,000 after buying an additional 36 shares during the last quarter. Parkside Financial Bank & Trust grew its position in shares of Astera Labs by 74.5% during the 2nd quarter. Parkside Financial Bank & Trust now owns 96 shares of the company’s stock worth $46,000 after buying an additional 41 shares during the period. Integrated Advisors Network LLC increased its stake in shares of Astera Labs by 4.8% in the 3rd quarter. Integrated Advisors Network LLC now owns 983 shares of the company’s stock valued at $350,000 after acquiring an additional 45 shares during the last quarter. Interchange Capital Partners LLC increased its stake in shares of Astera Labs by 4.4% in the 3rd quarter. Interchange Capital Partners LLC now owns 1,187 shares of the company’s stock valued at $423,000 after acquiring an additional 50 shares during the last quarter. Finally, Glenmede Trust Co. NA increased its stake in shares of Astera Labs by 2.7% in the 1st quarter. Glenmede Trust Co. NA now owns 1,909 shares of the company’s stock valued at $209,000 after acquiring an additional 51 shares during the last quarter. Institutional investors own 60.47% of the company’s stock.

Astera Labs Stock Performance

Shares of ALAB opened at $216.18 on Wednesday. The firm has a market cap of $37.78 billion, a P/E ratio of 86.13 and a beta of 3.86. Astera Labs, Inc. has a twelve month low of $97.89 and a twelve month high of $499.48. The firm’s 50 day moving average price is $297.39 and its two-hundred day moving average price is $256.20.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings data on Tuesday, November 3rd. The company reported $1.32 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.19 by $0.13. Astera Labs had a net margin of 29.64% and a return on equity of 25.35%. The company had revenue of $584.90 million during the quarter, compared to the consensus estimate of $550.78 million. During the same quarter in the prior year, the firm earned $0.49 earnings per share. The firm’s revenue was up 153.6% compared to the same quarter last year. On average, sell-side analysts anticipate that Astera Labs, Inc. will post 2.99 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on ALAB. UBS Group reduced their price objective on shares of Astera Labs from $300.00 to $290.00 and set a “neutral” rating on the stock in a research note on Wednesday, November 4th. Jefferies Financial Group boosted their price objective on shares of Astera Labs from $270.00 to $450.00 and gave the company a “buy” rating in a report on Wednesday, August 5th. BMO Capital Markets assumed coverage on shares of Astera Labs in a research note on Thursday, November 5th. They issued an “outperform” rating and a $375.00 target price for the company. Northland Securities upgraded shares of Astera Labs from a “market perform” rating to an “outperform” rating and set a $315.00 target price on the stock in a report on Wednesday, November 4th. Finally, Royal Bank Of Canada reduced their price target on shares of Astera Labs from $500.00 to $400.00 and set an “outperform” rating on the stock in a research report on Wednesday, November 4th. Thirteen analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company. Based on data from MarketBeat, Astera Labs currently has a consensus rating of “Moderate Buy” and a consensus price target of $320.85.

Key Astera Labs News

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Astera’s strong third-quarter results and outlook, alongside increasing sales of higher-value Scorpio switches, underpin the growth case. A recent report cited $585 million in Q3 revenue and $740 million midpoint guidance for Q4. Article: Astera Labs Is Increasing Their Revenue Per Accelerator
• Positive Sentiment: Shares rallied 14% in the prior session amid a technology-stock surge, signaling potential support from stronger sector sentiment. Article: Astera Labs rallies 14% on tech stock surge
• Neutral Sentiment: Astera will participate in the BMO Technology and Innovation Leaders Conference on November 12. The event could provide a venue for updates, but no new business announcement was included. Article: Astera Labs Announces Upcoming Financial Conference Participation
• Negative Sentiment: ETFs were net sellers of $80.2 million in ALAB on November 6, pointing to institutional outflow pressure. Article: ETFs Are Net Sellers of Astera Labs
• Negative Sentiment: Northland Securities lowered several 2027 quarterly EPS estimates and cut its FY2027 forecast to $4.79 from $5.43. It retained an Outperform rating and $315 target, while raising estimates for FY2026 and Q1 2027—making the revisions mixed overall.
• Negative Sentiment: A director disclosed sales totaling about 12,499 shares under a prearranged Rule 10b5-1 plan, which may concern investors despite the planned nature of the transactions. SEC Form 4 filing

Insiders Place Their Bets

In other Astera Labs news, Director Stefan A. Dyckerhoff sold 8,994 shares of the stock in a transaction dated Thursday, November 5th. The stock was sold at an average price of $211.41, for a total transaction of $1,901,421.54. Following the completion of the transaction, the director owned 1,987 shares in the company, valued at approximately $420,071.67. This represents a 81.91% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, COO Sanjay Gajendra sold 90,630 shares of the stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $340.35, for a total value of $30,845,920.50. Following the transaction, the chief operating officer owned 1,119,038 shares of the company’s stock, valued at approximately $380,864,583.30. This trade represents a 7.49% decrease in their position. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold a total of 408,558 shares of company stock worth $126,050,884 in the last ninety days. 10.40% of the stock is owned by insiders.

Astera Labs Company Profile

Astera Labs, Inc. is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help move data among processors, accelerators, memory and other components in high-performance computing systems. The company’s portfolio includes Aries PCIe and CXL retimers, Taurus Ethernet smart cable modules, Scorpio fabric switches and Leo CXL memory connectivity controllers. Astera Labs also offers software tools to help customers configure and monitor its connectivity products.